Cargando…

Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges

BACKGROUND: Chronic osteomyelitis is a catastrophic sequel of delayed diagnosis of acute osteomyelitis. OBJECTIVES: The objectives of the study were to determine bacterial flora and antibiotic sensitivity, and to evaluate the outcome of an aggressive surgical approach to chronic osteomyelitis. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerzy, Kuzma, Francis, Hombhanje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925860/
https://www.ncbi.nlm.nih.gov/pubmed/29755606
http://dx.doi.org/10.2174/1874325001812010153
_version_ 1783318782933991424
author Jerzy, Kuzma
Francis, Hombhanje
author_facet Jerzy, Kuzma
Francis, Hombhanje
author_sort Jerzy, Kuzma
collection PubMed
description BACKGROUND: Chronic osteomyelitis is a catastrophic sequel of delayed diagnosis of acute osteomyelitis. OBJECTIVES: The objectives of the study were to determine bacterial flora and antibiotic sensitivity, and to evaluate the outcome of an aggressive surgical approach to chronic osteomyelitis. METHODS: This is a single surgeon, prospective cohort study on 30 consecutive patients with clinically and radiologically diagnosed chronic osteomyelitis presented to a hospital. We prospectively recorded demographic, clinical, radiological features, treatment protocol, microbiologic results of culture and sensitivity. The main treatment outcome measures were clinical signs of eradication of infection. RESULTS: Microbiologic results showed that Gram-negative and mixed flora accounts for more than half of chronic osteomyelitis cases while Staphylococcus aureus was a dominating single pathogen (39%). We detected a high resistance rate to common antibiotics, e.g. 83% of S. aureus isolates were resistant to oxacillin (MRSA). The mean duration of bone infection was 4.2 years (3 months to 30 years) and the mean number of operations was 1.5 (1-5) . The mean follow-up was 15 months (12-18 months). Infection was eradicated in 95% (21 out of 22) treated by a single procedure and in all patients (n=8) by double procedure. CONCLUSION: Presented the high rate of MRSA strains is alarming and calls for updating of the antibiotic therapy guidelines in the country. Good results in treatment of chronic osteomyelitis can be achieved by a single-stage protocol including radical debridement combined with systemic and topical antibiotic.
format Online
Article
Text
id pubmed-5925860
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-59258602018-05-11 Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges Jerzy, Kuzma Francis, Hombhanje Open Orthop J Dentistry BACKGROUND: Chronic osteomyelitis is a catastrophic sequel of delayed diagnosis of acute osteomyelitis. OBJECTIVES: The objectives of the study were to determine bacterial flora and antibiotic sensitivity, and to evaluate the outcome of an aggressive surgical approach to chronic osteomyelitis. METHODS: This is a single surgeon, prospective cohort study on 30 consecutive patients with clinically and radiologically diagnosed chronic osteomyelitis presented to a hospital. We prospectively recorded demographic, clinical, radiological features, treatment protocol, microbiologic results of culture and sensitivity. The main treatment outcome measures were clinical signs of eradication of infection. RESULTS: Microbiologic results showed that Gram-negative and mixed flora accounts for more than half of chronic osteomyelitis cases while Staphylococcus aureus was a dominating single pathogen (39%). We detected a high resistance rate to common antibiotics, e.g. 83% of S. aureus isolates were resistant to oxacillin (MRSA). The mean duration of bone infection was 4.2 years (3 months to 30 years) and the mean number of operations was 1.5 (1-5) . The mean follow-up was 15 months (12-18 months). Infection was eradicated in 95% (21 out of 22) treated by a single procedure and in all patients (n=8) by double procedure. CONCLUSION: Presented the high rate of MRSA strains is alarming and calls for updating of the antibiotic therapy guidelines in the country. Good results in treatment of chronic osteomyelitis can be achieved by a single-stage protocol including radical debridement combined with systemic and topical antibiotic. Bentham Open 2018-03-30 /pmc/articles/PMC5925860/ /pubmed/29755606 http://dx.doi.org/10.2174/1874325001812010153 Text en © 2018 Jerzy and Francis. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dentistry
Jerzy, Kuzma
Francis, Hombhanje
Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges
title Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges
title_full Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges
title_fullStr Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges
title_full_unstemmed Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges
title_short Chronic Osteomyelitis - Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges
title_sort chronic osteomyelitis - bacterial flora, antibiotic sensitivity and treatment challenges
topic Dentistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925860/
https://www.ncbi.nlm.nih.gov/pubmed/29755606
http://dx.doi.org/10.2174/1874325001812010153
work_keys_str_mv AT jerzykuzma chronicosteomyelitisbacterialfloraantibioticsensitivityandtreatmentchallenges
AT francishombhanje chronicosteomyelitisbacterialfloraantibioticsensitivityandtreatmentchallenges